Caută instrumente

biotech

ETF Name

IBB_CFD.ETF

Market

Stocks

Costs

0.06 %

Daily

---

Weekly

---

Yearly

---

Biotech

ISHARES NASDAQ BIOTECH ETF

IBB_CFD.ETF

The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.
Limited-Time Offer:

Until 30 June 2026, enjoy zero commission on your first 10 ETF trades each month. This applies to trades with a total turnover of up to EUR 200,000 monthly. Please review the promotional Terms and Conditions for full details. The lowest commission within the 30 days prior to this offer was 0.1% (minimum 5 PLN / 1 USD / 1 EUR).

Portfolio composition (TOP 10)

09.04.2025
Amgen Inc.
Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.
Illumina, Inc.
Biogen Inc.
Moderna, Inc.
Seattle Genetics, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.

Biotech

ISHARES NASDAQ BIOTECH ETF

IBB_CFD.ETF

Daily

---

Weekly

---

Yearly

---
The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.

ETF Name

IBB_CFD.ETF

Market

Stocks

Costs

0.06 %

Limited-Time Offer:

Until 30 June 2026, enjoy zero commission on your first 10 ETF trades each month. This applies to trades with a total turnover of up to EUR 200,000 monthly. Please review the promotional Terms and Conditions for full details. The lowest commission within the 30 days prior to this offer was 0.1% (minimum 5 PLN / 1 USD / 1 EUR).

Portfolio composition (TOP 10)

09.04.2025
Amgen Inc.
Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.
Illumina, Inc.
Biogen Inc.
Moderna, Inc.
Seattle Genetics, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Vinde Cumpără
BID 0.0000
ASK 0.0000

Instrument specification for ISHARES NASDAQ BIOTECH ETF

Nume
Minimum order value
Description
Maximum order value
Transaction Step
Tip
Trading Hours
Contract size / 1 lot
Deposit required
Value of 1 pip
Financial leverage
Minimal step
Long swap (daily)
Short sale NO
Short swap (daily)
Distance SL and TP 0
3-day swap (date)
Learn more about Oanda account

Începe să tranzacționezi acum cu deschiderea rapidă a contului.

Înscrie-te acum pentru a tranzacționa pe cele mai active piețe

CONTO DESCHIS
Cu peste 20 de ani de experiență pe piețe, instrumente de analiză de vârf și mii de clienți mulțumiți, OANDA se mândrește cu faptul că este un broker premiat.
Obține acces la cele mai active piețe globale, cu mii de instrumente de tranzacționare la îndemână, precum și instrumente tehnice de vârf care te ajută în analiză.
Tranzacționează fără costuri inutile și cu transparență totală a prețurilor - OANDA oferă zero comisioane pentru instrumentele principale și prețuri transparente.
Scroll to top